Cambridge Design Partnership develops new uterine balloon tamponade (UBT) device
Cambridge Design Partnership has announced the development of a new novel uterine balloon tamponade (UBT) to control postpartum haemorrhage (PPH)…
Cambridge Design Partnership has announced the development of a new novel uterine balloon tamponade (UBT) to control postpartum haemorrhage (PPH)…
US-based SetPoint Medical has selected Sagentia as a development partner for its neuromodulation device indicated for chronic inflammatory disease.The company…
GE Healthcare has announced the US Food and Drug Administration (FDA) approval for Vizamyl (Flutemetamol F18 injection), a radioactive diagnostic…
Lumenis, a developer of medical laser equipment for the surgical and ophthalmology markets, has announced plans to introduce a new…